The North America negative pressure wound therapy devices Market is accounted to reach USD 2,511.2 million by 2024 from USD 1,544.8 million in 2016, at a CAGR of 5.8% in the forecast period 2017 to 2024

The major factors driving the growth of this market are rising aging and geriatric population and technological advancement in negative pressure wound therapy devices increased number of surgical procedures, government support for promoting negative pressure wound therapy rising incidence of diabetes. On the other hand, high cost of products and availability of substitute products hinders the market growth.

The key market players for North America negative pressure wound therapy devices Market are listed below;

Acelity L.P. Inc.
Smith & Nephew
M?lnlycke Health Care AB.

The market is further segmented into;
product type
wound type
end-user
distribution channel
Geography

North America negative pressure wound therapy devices market is segmented on the basis of product type, wound type, end user and distribution channel. On the basis of product type, the North America negative pressure wound therapy devices market is segmented into stand-alone negative-pressure wound therapy devices, portable negative-pressure wound therapy devices and disposable negative-pressure wound therapy devices. In 2017, standalone negative pressure wound therapy devices segment is expected to dominate the North America negative pressure wound therapy devices market with 47.4% market share and is expected to reach USD 942.7 million by 2024, growing with a CAGR of 2.3% in the forecast period 2017 to 2024.
On the basis of wound type, North America negative pressure wound therapy devices market is segmented into surgical wound, diabetic ulcers, burns, pressure ulcers, venous ulcers and others. In 2017, surgical wound is expected to dominate the North America negative pressure wound therapy devices market with 46.8% market share and is expected to reach USD 1,139.3 million by 2024, growing with a CAGR of 5.3% in the forecast period 2017 to 2024.
On the basis of end-user, North America negative pressure wound therapy devices market is segmented into hospitals, wound care centres, ambulatory centres, home healthcare, clinics and community healthcare. In 2017, hospital is expected to dominate the North America negative pressure wound therapy devices market with 41.4% market share and is expected to reach USD 754.5 million by 2024, growing with a CAGR of 1.0% in the forecast period 2017 to 2024.
On the basis of distribution channel, North America negative pressure wound therapy devices market is segmented into direct tenders and distributor & retails. In 2017, direct tenders is expected to dominate the North America negative pressure wound therapy devices market with 76.6% market share and is expected to reach USD 2,038.1 million by 2024, growing with the highest CAGR of 6.7% in the forecast period 2017 to 2024.


Based on geography, the North America Negative Pressure Wound Therapy Devices market is segmented into geographical regions, such as,
U.S.,
Canada
Mexico

Covered in this report
The report covers the present scenario and the growth prospects of the North America Negative Pressure Wound Therapy Devices market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.